Cargando…
An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information
BACKGROUND: With the approval of topical retapamulin ointment in 2011, it was officially required to conduct a post-marketing surveillance (PMS) study to obtain further data of its safety profile and effectiveness, in accordance with the requirement of the Korean Ministry of Food and Drug Safety (MF...
Autores principales: | Hong, Woosung, Lee, Yil-Seob, Park, Chun-Wook, Yoon, Moon-Soo, Ro, Young Suck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029962/ https://www.ncbi.nlm.nih.gov/pubmed/30065584 http://dx.doi.org/10.5021/ad.2018.30.4.441 |
Ejemplares similares
-
Topical retapamulin in the management of infected traumatic skin lesions
por: Shawar, Ribhi, et al.
Publicado: (2009) -
In Vitro Antimicrobial Activities of Fusidic Acid and Retapamulin against Mupirocin- and Methicillin-Resistant Staphylococcus aureus
por: Park, Sang Hyun, et al.
Publicado: (2015) -
Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance
por: Chen, Wenjing, et al.
Publicado: (2020) -
Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections()
por: Bohaty, Benjamin R., et al.
Publicado: (2015) -
A Validation Study for the Korean Version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT)
por: Hwang, Yong Il, et al.
Publicado: (2013)